R&D Healthcare brands are caught in a data privacy trap The digital advertising industry must adapt or accept the consequences of compliance failures.
Views & Analysis How the EU’s GDPR will be a positive catalyst for change Now that the GDPR deadline of May 25 has come and gone, many life sciences companies will have come to realise that GDPR compliance is not simply a legal problem or an IT project, but an enterprise
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
